Estats Units - anglès - NLM (National Library of Medicine)

rxhomeo private limited d.b.a. rxhomeo, inc - barium chloride dihydrate (unii: el5gj3u77e) (barium cation - unii:v645272hln) - barium chloride dihydrate 6 [hp_x] - mumps, tinnitus condition listed above or as directed by the physician

Estats Units - anglès - NLM (National Library of Medicine)

rxhomeo private limited d.b.a. rxhomeo, inc - barium carbonate (unii: 6p669d8hq8) (barium cation - unii:v645272hln) - barium carbonate 6 [hp_x] - swollen tonsils, cysts condition listed above or as directed by the physician

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

mci aust pty ltd - barium sulfate, quantity: 22 mg/ml - enema - excipient ingredients: sodium polymetaphosphate; carmellose sodium; aluminium magnesium silicate; sodium citrate dihydrate; sorbic acid; docusate sodium; sorbitol solution (70 per cent) (non-crystallising); saccharin sodium; simethicone; sodium methyl hydroxybenzoate; sodium propyl hydroxybenzoate; sodium butyl hydroxybenzoate; phosphoric acid; purified water; flavour - radiological diagnostic aid.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

mci aust pty ltd - barium sulfate, quantity: 1250 mg/ml - liquid, multipurpose - excipient ingredients: sodium citrate dihydrate; sodium polymetaphosphate; phosphoric acid; sorbic acid; saccharin sodium; carmellose sodium; docusate sodium; purified water; aluminium magnesium silicate; sorbitol solution (70 per cent) (non-crystallising); flavour; dimeticone 100; peg-4 stearate; glyceryl distearate; peg-3 distearate; peg-20 stearate; simethicone; sodium methyl hydroxybenzoate; sodium ethyl hydroxybenzoate; sodium propyl hydroxybenzoate - evidence not provided by sponsor.

Estats Units - anglès - NLM (National Library of Medicine)

genus medical technologies, llc - barium sulfate (unii: 25bb7eke2e) (barium sulfate - unii:25bb7eke2e) - indications and usage: for use as a contrast agent in radiographic studies. contraindications: this product should not be used in patients with known or suspected gastric or intestinal perforation, or hypersensitivity to barium sulfate or any component of this barium sulfate formulation; in patients with known or suspected obstruction of the colon; suspected tracheoesophageal fistula; obstructing lesions of the small intestine; pyloric stenosis; inflammation or neoplastic lesions of the rectum; or in patients who have had a recent rectal biopsy. barium sulfate suspensions should not be used for infants with swallowing disorders or for newborns with complete duodenal or jejunal obstruction or when distal small bowel or colon obstruction is suspected. barium sulfate suspension is not recommended for very small preterm infants and young babies requiring small volumes of contrast media or for infants and young children when there is a possibility of leakage from the gastrointestinal tract, such as nectrotizing

Estats Units - anglès - NLM (National Library of Medicine)

e-z-em canada inc - barium sulfate (unii: 25bb7eke2e) (barium sulfate - unii:25bb7eke2e) - for use in computed tomography to opacify the gi tract. this product should not be used in patients with known or suspected gastrointestinal perforation or hypersensitivity to barium sulfate or any component of this barium sulfate formulation.

Regne Unit - anglès - VMD (Veterinary Medicines Directorate)

cross vetpharm group ltd - selenium -

Irlanda - anglès - HPRA (Health Products Regulatory Authority)

bracco uk limited - barium sulfate - cachet - 49.2 mg/ml

Irlanda - anglès - HPRA (Health Products Regulatory Authority)

bracco uk limited - barium sulfate - powder for oral suspension - 98.45%w/w %w/w

Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

bracco uk ltd - barium sulfate - oral suspension